Connor G Policastro1, Jay Simhan2, Francisco E Martins3, Nicolaas Lumen4, Krishnan Venkatesan5,6, Javier C Angulo7, Shubham Gupta8, Paul Rusilko9, Erick Alejandro Ramírez Pérez10, Kirk Redger11, Brian J Flynn11, Michael Hughes1, Stephen Blakely1, Dmitriy Nikolavsky12. 1. Department of Urology, SUNY Upstate Medical University, 750 E Adams St, CWB 2nd Floor, Syracuse, NY, 13210, USA. 2. Einstein Medical Center/Fox Chase Cancer Center, Philadelphia, PA, USA. 3. University of Lisbon, Hospital Santa Maria, Lisbon, Portugal. 4. Ghent University, Ghent, Belgium. 5. Georgetown University, Washington, DC, USA. 6. MedStar Washington Hospital Center, Washington, DC, USA. 7. Departemento Clinico, Universidad Europea de Madrid, Hospital Universitario de Getafe, Madrid, Spain. 8. Case Western Reserve University, Cleveland, OH, USA. 9. University of Pittsburgh, Pittsburgh, PA, USA. 10. Centro de Uretra Mexico, Hospital Angeles MOCEL, Mexico City, Mexico. 11. University of Colorado, Aurora, CO, USA. 12. Department of Urology, SUNY Upstate Medical University, 750 E Adams St, CWB 2nd Floor, Syracuse, NY, 13210, USA. dnikolavsky@hotmail.com.
Abstract
PURPOSE: To critically evaluate a multi-institutional patient cohort undergoing Dorsal-Onlay Buccal Mucosal Graft Urethroplasty (D-BMGU) for recurrent post-radiation posterior urethral stenosis. METHODS: Retrospective multi-institutional review of patients with posterior urethral stenosis from 10 institutions between 2010-2019 was performed. Patients with at least 1-year follow-up were assessed. Patient demographics, stenosis characteristics, peri-operative outcomes, and post-operative clinical and patient-reported outcomes were analyzed. The primary outcomes were stenosis recurrence and de-novo stress urinary incontinence (SUI). Secondary outcomes were changes in voiding, sexual function, and patient-reported satisfaction. RESULTS: Seventy-nine men with post-radiation urethral stenosis treated with D-BMGU met inclusion criteria. Median age and stenosis length were 72 years, (IQR 66-75), and 3.0 cm (IQR 2.5-4 cm), respectively. Radiation modalities included: 36 (45.6%) external beam radiotherapy (EBRT), 13 (16.5%) brachytherapy (BT), 10 (12.7%) combination EBRT/BT, and 20 (25.3%) EBRT/radical prostatectomy. At a median follow-up of 21 months (IQR 13-40), 14 patients (17.7%) had stenosis recurrence. Among 37 preoperatively-continent patients, 3 men (8.1%) developed de-novo SUI following dorsal onlay urethroplasty. Of 29 patients with preoperative SUI all but one remained incontinent post-operatively (96.6%). Following repair, patients experienced significant improvement in PVR (92.5 to 26 cc, p = 0.001) and Uroflow (4.6 to 15.9 cc/s, p = 0.001), and high overall satisfaction, with 91.9% reporting a GRA of + 2 or better). CONCLUSION: Dorsal onlay buccal mucosa graft urethroplasty is a safe and feasible technique in patients with post-radiation posterior urethral stenosis. This non-transecting approach may confer low rates of de-novo SUI. Further research is needed to compare this technique with excisional urethroplasty.
PURPOSE: To critically evaluate a multi-institutional patient cohort undergoing Dorsal-Onlay Buccal Mucosal Graft Urethroplasty (D-BMGU) for recurrent post-radiation posterior urethral stenosis. METHODS: Retrospective multi-institutional review of patients with posterior urethral stenosis from 10 institutions between 2010-2019 was performed. Patients with at least 1-year follow-up were assessed. Patient demographics, stenosis characteristics, peri-operative outcomes, and post-operative clinical and patient-reported outcomes were analyzed. The primary outcomes were stenosis recurrence and de-novo stress urinary incontinence (SUI). Secondary outcomes were changes in voiding, sexual function, and patient-reported satisfaction. RESULTS: Seventy-nine men with post-radiation urethral stenosis treated with D-BMGU met inclusion criteria. Median age and stenosis length were 72 years, (IQR 66-75), and 3.0 cm (IQR 2.5-4 cm), respectively. Radiation modalities included: 36 (45.6%) external beam radiotherapy (EBRT), 13 (16.5%) brachytherapy (BT), 10 (12.7%) combination EBRT/BT, and 20 (25.3%) EBRT/radical prostatectomy. At a median follow-up of 21 months (IQR 13-40), 14 patients (17.7%) had stenosis recurrence. Among 37 preoperatively-continent patients, 3 men (8.1%) developed de-novo SUI following dorsal onlay urethroplasty. Of 29 patients with preoperative SUI all but one remained incontinent post-operatively (96.6%). Following repair, patients experienced significant improvement in PVR (92.5 to 26 cc, p = 0.001) and Uroflow (4.6 to 15.9 cc/s, p = 0.001), and high overall satisfaction, with 91.9% reporting a GRA of + 2 or better). CONCLUSION: Dorsal onlay buccal mucosa graft urethroplasty is a safe and feasible technique in patients with post-radiation posterior urethral stenosis. This non-transecting approach may confer low rates of de-novo SUI. Further research is needed to compare this technique with excisional urethroplasty.
Authors: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Richard L Anderson; Zachariah A Allen; Edward Adamovich Journal: J Urol Date: 2006-04 Impact factor: 7.450
Authors: Sascha A Ahyai; Marianne Schmid; Marie Kuhl; Luis A Kluth; Armin Soave; Silke Riechardt; Felix K-H Chun; Oliver Engel; Margit Fisch; Roland Dahlem Journal: J Urol Date: 2015-04-04 Impact factor: 7.450
Authors: Matthias D Hofer; Lee C Zhao; Allen F Morey; J Francis Scott; Andrew J Chang; Steven B Brandes; Chris M Gonzalez Journal: J Urol Date: 2013-12-12 Impact factor: 7.450
Authors: Mohannad A Awad; Thomas W Gaither; E Charles Osterberg; Gregory P Murphy; Nima Baradaran; Benjamin N Breyer Journal: Prostate Cancer Prostatic Dis Date: 2018-01-02 Impact factor: 5.554
Authors: Joceline S Fuchs; Matthias D Hofer; Kunj R Sheth; Billy H Cordon; Jeremy M Scott; Allen F Morey Journal: Urology Date: 2016-08-02 Impact factor: 2.649
Authors: Cristina Esquinas; Sonia Ruiz; Elena de Sancha; Mónica Vazquez; Juan F Dorado; Miguel Virseda; Ignacio Arance; Javier C Angulo Journal: Adv Ther Date: 2020-11-23 Impact factor: 3.845